Login

Renren received a non-binding preliminary 'going private' offer from top executives at $4.20 per share in cash for each American depositary share. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Inside ArcherPoint: Our Business Approach in 90 Seconds
00:10:00
Lucas Lundin: Bullish on Copper, Gold, and Uranium for the Future
00:00:00
Work on the implementation of health programs with advancing health equity / Louise Ivers, MB, BCh, MD, MPH, DTM&H Professor of Global Health and Social Medicine, HMS
00:10:00
Empowering Small Farmers: Sri Lankan Agriculture Reaching Global Markets|Sarath Ganegoda,Executive Director,Hayleys Fibre PLC
00:10:00
Cadiz Inc. CEO Susan Kennedy outlines the company's evolution and vision for water management strategies in an interview with Proactive Investors New.
00:10:00
Aina Borch Introduces Kingsrose and BHP Exploration Alliances Plans
00:10:00
Medusa Mining Highlights Success and Expansion in Philippine Operations at One-to-One Conference
00:10:00
JLL CEO Discusses Long-Term Outlook for Office Space Amidst Changing Work Dynamics | Christian Ulbrich, CEO,  JLL Partners.
00:10:00
Lloyds Banking Group Announces Strong Results and Strategic Progress | Charlie Nunn, CEO, Lloyds Banking Group.
00:10:00
Exploring Market Trends with Jeff Krumpelman |
00:10:00
Ciena CEO Gary Smith discusses the company's distinctive focus on customer engagement.
00:10:00
Bruce Thornton on the Historical Lessons of Appeasement

© 2026 Nehu